Blog

12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines ...

2 August 2024 - A groundbreaking pan-tumour pharmaceutical that can act upon multiple different tumour types has been publicly funded ...

1 August 2024 - The August 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

31 July 2024 - Australians fighting lung and liver cancer will soon be able to access a life-saving cancer treatment ...

1 August 2024 - The August 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

29 July 2024 - With the addition of Alberta's public plan, Vascepa will be available to more than 90% of ...

29 July 2024 - Australian children with cystic fibrosis now have access to cheaper medicines earlier under the PBS thanks ...

2 July 2024 - Australians with early breast cancer, leukaemia, and types of lupus, and insomnia, will now have access to ...

1 July 2024 - July 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

1 July 2024 - The July 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

24 June 2024 - Australians with non-small cell lung cancer and the chronic skin disease hidradenitis suppurativa, now have access to ...

18 June 2024 - PHARMAC has changed the criteria for two breast cancer medicines which means people with a particular ...

1 June 2024 - The June 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

1 June 2024 - The June 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...